Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer

By  

The Women's Oncology Review, Vol. 4, Iss. 3, 2004-09 ,pp. : 211-213

Informa Healthcare

Access to resources Recommend Favorite

Progress in Evaluation of Pathologic Response to Neoadjuvant Chemotherapy of Breast Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 2, 2013-02 ,pp. : 222-226

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Usefulness of AJCC Response Criteria for Neoadjuvant Chemotherapy in Breast Cancer

By Keam Bhumsuk   Im Seock-Ah   Lim Yoojoo   Han Sae-Won   Moon Hyeong-Gon   Oh Do-Youn   Cho Nariya   Lee Se-Hoon   Han Wonshik   Moon Woo   Kim Dong-Wan   Kim Tae-You   Park In   Noh Dong-Young  

Annals of Surgical Oncology, Vol. 20, Iss. 7, 2013-07 ,pp. : 2242-2249

Springer Publishing Company

Access to resources Recommend Favorite

Impact of weight change during neoadjuvant chemotherapy on pathologic response in triple‐negative breast cancer

By  

Cancer Medicine, Vol. 4, Iss. 4, 2015-04 ,pp. : 500-506

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pathological complete response in breast cancer patients following neoadjuvant chemotherapy at a Comprehensive Cancer Center: The natural history of an elusive prognosticator

By        

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 775-780

Science Publishers

Access to resources Recommend Favorite